• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Cytosorbents Corporation - Common Stock (NQ:CTSO)

    0.6529 +0.0229 (+3.63%)
    Streaming Delayed Price Updated: 3:29 PM EST, Feb 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 46,942
    Open 0.6600
    Bid (Size) 0.6400 (1,000)
    Ask (Size) 0.6659 (200)
    Prev. Close 0.6300
    Today's Range 0.6300 - 0.6698
    52wk Range 0.6000 - 1.610
    Shares Outstanding 54,679,569
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Top movers in Tuesday's pre-market session ↗
    As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill
    News headline image
    Cytosorbents Corp (NASDAQ:CTSO) Posts Mixed Q3 2025 Results Amidst Stock Volatility ↗
    Cytosorbents Q3 2025 earnings show a mixed quarter, beating EPS estimates but missing on revenue. The stock saw volatility despite a strengthened balance sheet. 
    Via Chartmill

    Performance

    YTD
    -0.4%
    -0.4%
    1 Month
    -10.6%
    -10.6%
    3 Month
    -1.9%
    -1.9%
    6 Month
    -42.7%
    -42.7%
    1 Year
    -43.2%
    -43.2%

    More News

    Read More
    News headline image
    Cytosorbents (CTSO) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Earnings Scheduled For November 13, 2025 ↗
    Via Benzinga
    News headline image
    Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings) ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    CytoSorbents's Earnings: A Preview ↗
    Via Benzinga
    News headline image
    Insights into CytoSorbents's Upcoming Earnings ↗
    Via Benzinga
    News headline image
    Wednesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Demystifying CytoSorbents: Insights From 5 Analyst Reviews ↗
    Via Benzinga
    News headline image
    CytoSorbents Corp (NASDAQ:CTSO) Reports Mixed Q2 2025 Earnings with Revenue Beat and Narrower Loss ↗
    Via Chartmill
    News headline image
    A Glimpse Into The Expert Outlook On CytoSorbents Through 5 Analysts ↗
    Via Benzinga
    News headline image
    Top movers in Wednesday's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Gapping stocks in Wednesday's session ↗
    Via Chartmill
    News headline image
    Deep Dive Into CytoSorbents Stock: Analyst Perspectives (6 Ratings) ↗
    Via Benzinga
    News headline image
    Demystifying CytoSorbents: Insights From 4 Analyst Reviews ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For May 14, 2025 ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    The Analyst Verdict: CytoSorbents In The Eyes Of 4 Experts ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For March 31, 2025 ↗
    Via Benzinga
    News headline image
    CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
    From CytoSorbents
    Via GlobeNewswire

    Frequently Asked Questions

    Is Cytosorbents Corporation - Common Stock publicly traded?
    Yes, Cytosorbents Corporation - Common Stock is publicly traded.
    What exchange does Cytosorbents Corporation - Common Stock trade on?
    Cytosorbents Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Cytosorbents Corporation - Common Stock?
    The ticker symbol for Cytosorbents Corporation - Common Stock is CTSO on the Nasdaq Stock Market
    What is the current price of Cytosorbents Corporation - Common Stock?
    The current price of Cytosorbents Corporation - Common Stock is 0.6529
    When was Cytosorbents Corporation - Common Stock last traded?
    The last trade of Cytosorbents Corporation - Common Stock was at 02/13/26 03:29 PM ET
    What is the market capitalization of Cytosorbents Corporation - Common Stock?
    The market capitalization of Cytosorbents Corporation - Common Stock is 35.70M
    How many shares of Cytosorbents Corporation - Common Stock are outstanding?
    Cytosorbents Corporation - Common Stock has 36M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.